Invex Therapeutics is a biopharmaceutical company that specializes in repurposing an existing drug, Exenatide, for the treatment of neurological conditions caused by, or related to, raised intracranial pressure. The company focuses on conditions such as Idiopathic Intracranial Hypertension (IIH), acute stroke, and traumatic brain injury. It has trademarked its repurposed Exenatide as Presendin™.
Invex Therapeutics Ltd's ticker is IXC
The company's shares trade on the ASX stock exchange
They are based in Subiaco, Australia
There are 1-10 employees working at Invex Therapeutics Ltd
It is https://invextherapeutics.com/
Invex Therapeutics Ltd is in the Healthcare sector
Invex Therapeutics Ltd is in the Biotechnology industry
The following five companies are Invex Therapeutics Ltd's industry peers: